METHOD FOR PREDICTING SENSITIVITY OF OSTEOSARCOMA PATIENT TO ANTICANCER AGENT

摘要

The present invention provides a method for predicting sensitivity of an osteosarcoma patient to an anticancer agent based on the value indicating the expression level of at least one of miRNA-100 and miRNA-125b in RNA extracted from a biological sample containing osteosarcoma cells collected from the osteosarcoma patient to whom the anticancer agent is not administered. Thus, the present invention allows the prediction of sensitivity of the osteosarcoma patient to the anticancer agent before administration of the anticancer agent.